PepGen

PepGen EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of PepGen (PEPG) as of Nov 19, 2026 is -3.33. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -3.49 — a change of -4.75% (higher).

EV/EBITDA

-3.33

YoY

-4.75%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of PepGen is 2025 -3.33 . EV/EBITDA (Enterprise Value to EBITDA) of PepGen was 2024 -3.49 . It decreases by -4.75% higher compared to the previous year.

The PepGen EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2019
-324.41 USD
Jan 1, 2020
-230.67 USD
Jan 1, 2021
-11.43 USD
Jan 1, 2022
-4.18 USD
Jan 1, 2023
-4.16 USD
Jan 1, 2024
-3.49 USD
Jan 1, 2025
-3.33 USD
The PepGen EV/EBITDA history
YEAREV/EBITDAYoY
-3.33-4.75%
-3.49-16.04%
-4.16-0.54%
-4.18-63.43%
-11.43-95.04%
-230.67-28.90%
-324.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen Stock analysis

What does PepGen do? PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees. PepGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PepGen stock

EV/EBITDA (Enterprise Value to EBITDA) of PepGen is -3.33 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of PepGen changed from -3.49 to -3.33, representing a -4.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) PepGen since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s PepGen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — PepGen

All Key Metrics — PepGen